Dr Pilar Garrido presents at ecancer's Milan Summit on Precision Medicine 2018 about the current situation regarding lung cancer and precision medicine.
She outlines some of the genomic targets for lung cancer, including immunotherapy biomarkers.
Dr Garrido also gives her thoughts on the challenges when using NGS.
The webcast has been supported by an unrestricted educational grant from Roche Foundation Medicine